日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial

贝伐珠单抗、伊立替康或拓扑替康联合替莫唑胺治疗复发难治性神经母细胞瘤患儿:ITCC-SIOPEN BEACON-神经母细胞瘤试验结果

Moreno, Lucas; Weston, Rebekah; Owens, Cormac; Valteau-Couanet, Dominique; Gambart, Marion; Castel, Victoria; Zwaan, C Michel; Nysom, Karsten; Gerber, Nicolas; Castellano, Aurora; Laureys, Genevieve; Ladenstein, Ruth; Rössler, Jochen; Makin, Guy; Murphy, Dermot; Morland, Bruce; Vaidya, Sucheta; Thebaud, Estelle; van Eijkelenburg, Natasha; Tweddle, Deborah A; Barone, Giuseppe; Tandonnet, Julie; Corradini, Nadege; Chastagner, Pascal; Paillard, Catherine; Bautista, Francisco J; Gallego Melcon, Soledad; De Wilde, Bram; Marshall, Lynley; Gray, Juliet; Burchill, Susan A; Schleiermacher, Gudrun; Chesler, Louis; Peet, Andrew; Leach, Martin O; McHugh, Kieran; Hayes, Roisin; Jerome, Neil; Caron, Hubert; Laidler, Jennifer; Fenwick, Nicola; Holt, Grace; Moroz, Veronica; Kearns, Pamela; Gates, Simon; Pearson, Andrew D J; Wheatley, Keith

Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA

Liquidhope:利用极少量血浆来源的DNA进行甲基化组和基因组分析

Trinidad, Eva María; Vidal, Enrique; Coronado, Esther; Esteve-Codina, Anna; Castel, Victoria; Cañete, Adela; Gut, Marta; Heath, Simon; Font de Mora, Jaime

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas

利用电泳图分析和甲基化组分析评估高危神经母细胞瘤中的循环肿瘤DNA

Trinidad, Eva María; Juan-Ribelles, Antonio; Pisano, Giulia; Castel, Victoria; Cañete, Adela; Gut, Marta; Heath, Simon; Font de Mora, Jaime

Germline variant in Ctcf links mental retardation to Wilms tumor predisposition

Ctcf基因的种系变异与智力低下和肾母细胞瘤易感性相关

Gargallo, Pablo; Oltra, Silvestre; Tasso, María; Balaguer, Julia; Yáñez, Yania; Dolz, Sandra; Calabria, Inés; Martínez, Francisco; Segura, Vanessa; Juan-Ribelles, Antonio; Llavador, Margarita; Castel, Victoria; Cañete, Adela; Font de Mora, Jaime

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

欧洲神经母细胞瘤研究组(SIOPEN)高危神经母细胞瘤试验(HR-NBL1)中ALK扩增和突变的频率及预后影响

Bellini, Angela; Pötschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clément, Nathalie; Combaret, Valérie; Font de Mora, Jaime; George, Sally L; Jiménez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Mühlethaler-Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner-Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Geneviève; Luksch, Roberto; Malis, Josef; Popovic-Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau-Couanet, Dominique; Tweddle, Deborah A; Ladenstein, Ruth; Schleiermacher, Gudrun

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

神经母细胞瘤的药物遗传学:哪些已经可以应用于临床,哪些是下一步发展方向?

Olivera, Gladys G; Urtasun, Andrea; Sendra, Luis; Aliño, Salvador F; Yáñez, Yania; Segura, Vanessa; Gargallo, Pablo; Berlanga, Pablo; Castel, Victoria; Cañete, Adela; Herrero, María José

Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets

11q缺失型神经母细胞瘤的肿瘤内免疫抑制谱提供了新的潜在治疗靶点

Coronado, Esther; Yañez, Yania; Vidal, Enrique; Rubio, Luis; Vera-Sempere, Francisco; Cañada-Martínez, Antonio José; Panadero, Joaquín; Cañete, Adela; Ladenstein, Ruth; Castel, Victoria; Font de Mora, Jaime

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.

从下一代测序到医疗保健:儿童癌症的种系易感性

Gargallo Pablo, Oltra Silvestre, Yáñez Yania, Juan-Ribelles Antonio, Calabria Inés, Segura Vanessa, Lázaro Marián, Balaguer Julia, Tormo Teresa, Dolz Sandra, Fernández José María, Fuentes Carolina, Torres Bárbara, Andrés Mara, Tasso María, Castel Victoria, Font de Mora Jaime, Cañete Adela

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

肿瘤基因组学对局部可切除MYCN非扩增型神经母细胞瘤预后影响的年龄依赖性:SIOPEN生物学组关于LNESG试验和COG验证组的报告

Ambros, Inge M; Tonini, Gian-Paolo; Pötschger, Ulrike; Gross, Nicole; Mosseri, Véronique; Beiske, Klaus; Berbegall, Ana P; Bénard, Jean; Bown, Nick; Caron, Huib; Combaret, Valérie; Couturier, Jerome; Defferrari, Raffaella; Delattre, Olivier; Jeison, Marta; Kogner, Per; Lunec, John; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Noguera, Rosa; Schleiermacher, Gudrun; Valent, Alexander; Van Roy, Nadine; Villamon, Eva; Janousek, Dasa; Pribill, Ingrid; Glogova, Evgenia; Attiyeh, Edward F; Hogarty, Michael D; Monclair, Tom F; Holmes, Keith; Valteau-Couanet, Dominique; Castel, Victoria; Tweddle, Deborah A; Park, Julie R; Cohn, Sue; Ladenstein, Ruth; Beck-Popovic, Maja; De Bernardi, Bruno; Michon, Jean; Pearson, Andrew D J; Ambros, Peter F

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)

在SIOPEN高危神经母细胞瘤1试验(HR-NBL1)中,研究Dinutuximab Beta免疫疗法的作用

Ladenstein, Ruth; Pötschger, Ulrike; Valteau-Couanet, Dominique; Luksch, Roberto; Castel, Victoria; Ash, Shifra; Laureys, Genevieve; Brock, Penelope; Michon, Jean Marie; Owens, Cormac; Trahair, Toby; Chi Fung Chan, Godfrey; Ruud, Ellen; Schroeder, Henrik; Beck-Popovic, Maja; Schreier, Guenter; Loibner, Hans; Ambros, Peter; Holmes, Keith; Castellani, Maria Rita; Gaze, Mark N; Garaventa, Alberto; Pearson, Andrew D J; Lode, Holger N